Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1991 1
1993 1
1994 1
1996 2
1997 2
1998 3
1999 2
2001 4
2002 6
2003 4
2004 1
2005 3
2006 3
2007 6
2008 4
2009 8
2010 6
2011 2
2013 1
2014 4
2016 2
2017 2
2018 1
2019 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Results by year
Filters applied: . Clear all
Page 1
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability.
Methot JL, Zhou H, Kattar SD, McGowan MA, Wilson K, Garcia Y, Deng Y, Altman M, Fradera X, Lesburg C, Fischmann T, Li C, Alves S, Shah S, Fernandez R, Goldenblatt P, Hill A, Shaffer L, Chen D, Tong V, McLeod RL, Yu H, Bass A, Kemper R, Gatto NT, LaFranco-Scheuch L, Trotter BW, Guzi T, Katz JD. Methot JL, et al. Among authors: mcleod rl. J Med Chem. 2019 May 9;62(9):4370-4382. doi: 10.1021/acs.jmedchem.8b01818. Epub 2019 Apr 22. J Med Chem. 2019. PMID: 30986068
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation.
McLeod RL, Gil MA, Chen D, Cabal A, Katz J, Methot J, Woodhouse JD, Dorosh L, Geda P, Mehta K, Cicmil M, Baltus GA, Bass A, Houshyar H, Caniga M, Yu H, Gervais F, Alves S, Shah S. McLeod RL, et al. J Pharmacol Exp Ther. 2019 May;369(2):223-233. doi: 10.1124/jpet.118.252551. Epub 2019 Feb 25. J Pharmacol Exp Ther. 2019. PMID: 30804001
TRPV1 antagonists as potential antitussive agents.
McLeod RL, Correll CC, Jia Y, Anthes JC. McLeod RL, et al. Lung. 2008;186 Suppl 1:S59-65. doi: 10.1007/s00408-007-9032-z. Epub 2007 Oct 10. Lung. 2008. PMID: 17926096 Review.
Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1.
McLeod RL, Angagaw MH, Baral TN, Liu L, Moniz RJ, Laskey J, Hsieh S, Lee M, Han JH, Issafras H, Javaid S, Loboda A, Sadekova S, O'Connor JA, Tse A, Punnonen J. McLeod RL, et al. Oncotarget. 2018 Oct 2;9(77):34459-34470. doi: 10.18632/oncotarget.26108. eCollection 2018 Oct 2. Oncotarget. 2018. PMID: 30349641 Free PMC article.
alpha2-adrenoceptor agonists as nasal decongestants.
Corboz MR, Mutter JC, Rivelli MA, Mingo GG, McLeod RL, Varty L, Jia Y, Cartwright M, Hey JA. Corboz MR, et al. Among authors: mcleod rl. Pulm Pharmacol Ther. 2007;20(2):149-56. doi: 10.1016/j.pupt.2006.03.012. Epub 2006 May 6. Pulm Pharmacol Ther. 2007. PMID: 16809058
Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.
Jia Y, Chen K, Lin P, Lieber G, Nishi M, Yan R, Wang Z, Yao Y, Li Y, Whitson BA, Duann P, Li H, Zhou X, Zhu H, Takeshima H, Hunter JC, McLeod RL, Weisleder N, Zeng C, Ma J. Jia Y, et al. Among authors: mcleod rl. Nat Commun. 2014 Jul 18;5:4387. doi: 10.1038/ncomms5387. Nat Commun. 2014. PMID: 25034454 Free PMC article.
67 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page